Research On Asset-Light Operation Mode Transformation And Financial Performance Of Lizhu Group

In the recent period,the operating environment of the domestic pharmaceutical industry has changed dramatically.Various reform policies and new regulations have been introduced one after another.With the changes of market access rules and business ecology of the pharmaceutical industry,policies are changing and becoming more complex,with more regulations and tougher entry standards.Fake vaccines,toxic capsules and other negative events make all sectors of society focus on medical and health,and the commercial environment faced by the pharmaceutical manufacturing industry has undergone dramatic changes.And,under the background of the medicine industry scale continues to expand and enhance the rationality of the industrial division of labor,professional,and light asset operation mode in its own technology,a relatively high value-added link such as brand building advantages of,attracted a large number of enterprises are carried out,and academic research hot topic nowadays.In the past development stage,the pharmaceutical companies are typical asset-heavy industry.Under the background of China’s continuous reform of the medical system,transformation and upgrading are urgently needed.At present,a number of pharmaceutical manufacturing enterprises have begun to transform to an asset-light business model.This paper selects Lizhu Group,which has just transformed into asset-light operation model,as a case study.First,by studying relevant literature,it elaborates on the concept of asset-light and asset-light operations,and analyzes the theoretical basis for the emergence of asset-light models.Based on the development status of China’s pharmaceutical manufacturing industry,this paper analyzes the feasibility of pharmaceutical manufacturing enterprises to transform into asset-light operation mode.Then analyzes the transformation reasons and measures of Lizhu Group,and expounds the correlative financial characteristics.Next,13 evaluation indicators are selected from four different dimensions.Using the efficiency coefficient method,this paper compares the changes of financial performance of Lizhu before and after the transformation of asset-light operation mode from two different angles.Finally,it finds the shortcomings in the implementation of Lizhu Group’s asset-light operation model,and formulate a series of specific strategies.The research results show that Lizhu group has greatly improved its financial performance,implemented the asset-light operation mode.The development of the enterprise becomes stable.Furthermore,in view of the transformation process,this paper makes suggestions such as focusing on core capabilities,strengthening capital management and control,optimizing resource allocation,and exploring suitable development models to point out the direction for development of other pharmaceutical enterprises.